0001829126-22-016172.txt : 20220825 0001829126-22-016172.hdr.sgml : 20220825 20220825161958 ACCESSION NUMBER: 0001829126-22-016172 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220815 FILED AS OF DATE: 20220825 DATE AS OF CHANGE: 20220825 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McMurdo Matthew Charles CENTRAL INDEX KEY: 0001943108 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13341 FILM NUMBER: 221197631 MAIL ADDRESS: STREET 1: 1047 SEWARD AVE. CITY: WESTFIELD STATE: NJ ZIP: 07090 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000910267 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943171940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6502444990 MAIL ADDRESS: STREET 1: 400 OYSTER POINT BLVD STREET 2: SUITE 505 CITY: SAN FRANCISCO STATE: CA ZIP: 94080 3 1 ownership.xml 3 X0206 3 2022-08-15 0 0000910267 TITAN PHARMACEUTICALS INC TTNP 0001943108 McMurdo Matthew Charles C/O TITAN PHARMACEUTICALS, INC. 400 OYSTER POINT BLVD., SUITE 505 SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 0 D No securities are beneficially owned. /s/ Matthew C. McMurdo 2022-08-25